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the vascular dysfunction is the primary event in the occurrence of cardio-vascular risk, and no treatment 
exists until now. We tested for the first time the hypothesis that chitin-glucan (CG) - an insoluble fibre 
with prebiotic properties- and polyphenol-rich pomegranate peel extract (PPE) can improve endothelial 
and inflammatory disorders in a mouse model of cardiovascular disease (CVD), namely by modulating 
the gut microbiota. Male Apolipoprotein E knock-out (ApoE−/−) mice fed a high fat (HF) diet developed 
a significant endothelial dysfunction attested by atherosclerotic plaques and increasing abundance of 
caveolin-1 in aorta. The supplementation with CG + PPE in the HF diet reduced inflammatory markers 
both in the liver and in the visceral adipose tissue together with a reduction of hepatic triglycerides. 
in addition, it increased the activating form of endothelial no-synthase in mesenteric arteries and 
the heme-nitrosylated haemoglobin (Hb-NO) blood levels as compared with HF fed ApoE−/− mice, 
suggesting a higher capacity of mesenteric arteries to produce nitric oxide (NO). This study allows to 
pinpoint gut bacteria, namely Lactobacillus and Alistipes, that could be implicated in the management 
of endothelial and inflammatory dysfunctions associated with CVD, and to unravel the role of nutrition 
in the modulation of those bacteria.
Despite the enormous progress made in the diagnosis and treatment of cardiovascular diseases (CVDs) over the 
last twenty years, CVDs remain the leading cause of disability and death in Western countries1. Given the grow-
ing prevalence of obesity, type 2 diabetes and metabolic syndrome, it is estimated that the number of people with 
chronic cardiometabolic disease will continue to grow in the next two decades1,2. Obese individuals that develop 
atherosclerotic CVDs are often characterized by a low-grade chronic inflammation. It has been hypothesized 
that changes in inflammatory status partly explain the individual differences in cardiovascular risk2. Endothelial 
dysfunction is an early key marker of CVDs reflecting the integrated effects of risk factors on the vascular system3. 
It comes from the incapacity of endothelial cells to equilibrate synthesis and release of damaging or protective 
mediators, among which nitric oxide (NO) is the most important. The main feature of endothelial dysfunction is 
the inability of endothelium to promote vasodilation in response to agonist or shear forces4.
Apolipoprotein E (ApoE) is a key mediator for transport and reuptake of cholesterol. ApoE knock-out mice 
(ApoE−/−) are proposed as a model of atherosclerosis and endothelial dysfunction5. Endothelium-dependent 
relaxation is reduced in response to acetylcholine in 13-months-old ApoE−/− mice compared to wild-type 
mice6. However, this is not observed in youngest mice, suggesting that vascular disorders occurring in ApoE 
deficiency depend on age. Obesity are associated to altered vascular functions, with impaired vessel reactivity and 
lower endothelium-dependent relaxation. Interestingly, high fat (HF) diet feeding accelerates the process of ather-
osclerosis in ApoE−/− mice7. In addition, HF diets participate to worsening metabolic and vascular phenotypes 
which negatively influences the evolution of CVD in this murine model8,9.
The pathophysiology of CVDs is complex and involves multiple organs, establishing distant communications 
via bloodstream. Recently, a growing body of evidence has emerged regarding the critical role of gut microbiota 
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in CVDs and metabolic disorders1,10. The gut microbiota can be considered as a “microbial organ” under the 
influence of the diet and host factors. Hence, the gut microbiota and its activity are intricately intertwined with 
the physiology and pathophysiology of the host11–13. Obesity in humans has been associated with the composition 
and function of the gut microbiota, but only a few studies focus on the role of gut microbiota in the CVDs1.
Modulation of the diet with specific dietary components could be used to prevent atherosclerosis. Dietary 
fibre is thought to have beneficial effects on health because it is considered to reduce the risk of CVD. In humans, 
this effect could be attributed to a decrease in plasma LDL10,14. For years, we and others have demonstrated 
that dietary fibre supplementation modulates the composition of the gut microbiota, and eventually improves 
host physiology13,15,16. This is particularly the case for inulin-type fructans (ITF), which are classified as preb-
iotics. Prebiotics are ‘substrates that are selectively utilized by host microorganisms conferring a health bene-
fit’17. Whether CVD and atherosclerosis can be successfully treated by fibre targeting the microbiota is still not 
clear. ITF-fed ApoE −/− mice have been shown to have reduced cholesterol and atherosclerotic lesions com-
pared to control mice. However, the mechanism was unexplored18. Recently, we demonstrated that ITF improve 
endothelial dysfunction in ApoE−/− mice fed a n-3 PUFA-depleted diet and developing steatosis. We found 
that ITF-induced changes in gut microbiota linked endogenous GLP-1 production with an improved endothelial 
function19. If proven in humans, those studies suggest that prebiotics might be proposed as a novel approach in 
the prevention of metabolic disorders-related CVDs.
Chitin-glucan (CG) has been shown to modulate the human gut microbiota in the in vitro SHIME microbiota 
simulator20. In a previous study, we have highlighted beneficial effects of this insoluble fibre on the development 
of obesity and associated diabetes and hepatic steatosis in mice, through a mechanism related to the restoration 
of the composition and/or the activity of gut bacteria21.
In the present study, we have tested the prebiotic potency of chitin-glucan, an insoluble dietary fibre, alone or 
in combination with a pomegranate peel extract (PPE) rich in polyphenols in a model of accelerated atheroscle-
rosis in ApoE−/− mice fed a high fat diet during 8 weeks.
Results
chitin-glucan supplementation with or without pomegranate peel extract did not change high 
fat diet-induced body weight gain, fat mass expansion and hypercholesterolemia. The HF diet 
significantly increased body weight gain and the development of epididymal, visceral and subcutaneous adipose 
tissues of ApoE−/− mice as compared with control diet (Fig. 1 and Table 1). The fat mass increased upon HF 
feeding without reaching significance (Fig. 1). Liver weight and cholesterolemia were higher in HF-fed than in CT 
mice (Table 1). CG or CG + PPE supplementation did not significantly change those parameters. The lipid profile 
in the plasma was not affected by the dietary treatments (Table 1). Although this effect was not statistically signif-
icant due to large variability, CG with or without PPE decreased the level of ALAT in the serum (ALAT activity 
expressed in U/L: 16.4 ± 6.6, 16.6 ± 5.2, 6.7 ± 1.2, 8.8 ± 1.9 for CT, HF, CG and CG + PPE groups, respectively).
It is interesting to note that ApoE−/− mice upon HF feeding and treated with CG or CG + PPE exhibited the 
higher cecal tissue and cecal content weight compared to HF group; this effect reached statistical significance for 
the cecal tissue from the mice treated with the combination (Table 1).
chitin-glucan supplementation with pomegranate peel extract decreased hepatic content of 
triglycerides. The HF diet did not significantly affect lipid content, cholesterol content and triglyceride con-
tent of the liver tissue from the ApoE−/− mice compared to CT group as shown in Fig. 2(a–c). The supplemen-
tation with the CG in combination with PPE significantly reduced hepatic triglycerides (Fig. 2c). Fat staining of 
the tissue confirmed the lower fat accumulation in the liver even if the significance was not reached (Fig. 2d–f).
In addition, we measured the expression of two hepatic genes regulating lipid metabolism: fatty acid synthase 
(Fas), a key enzyme involved in lipogenesis and carnitine palmitoyl transferase-1 (Cpt1), a marker of fatty acid 
oxidation. None of the dietary treatments significantly affect Fas or Cpt1 expression (data not shown).
Figure 1. Body weight evolution (a), body weight gain (b) and fat mass gain (c) of ApoE−/− mice fed a low 
fat diet (CT), a high fat (HF) diet or a HF diet supplemented with 5% chitin-glucan (CG) or a combination of 
5% CG and 0.5% pomegranate peel extracts (CG + PPE) for 8 weeks. Data with different superscript letters are 
significantly different at p < 0.05 (one-way ANOVA); ns = non significant and *p < 0.05 (two-way ANOVA).
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Chitin-glucan supplementation with pomegranate peel extract reduced inflammatory markers 
both in adipose tissue and in the liver. HF diet has been reported to induce endotoxemia and inflam-
mation in the liver and the visceral adipose tissue22. In addition, our previous findings support that pomegranate 
extract alleviated tissue inflammation in HF diet-induced obese mice23. Therefore, we analyzed the expression of 
the target genes among others, in particular: two macrophage markers (CD11c, F4/80), the lipopolysaccharide 
binding protein (LBP), a key pattern recognition receptor (Toll-like Receptor-4 (TLR4)), one of the most potent 
chemokines identified for monocytes recruitment (monocyte chemotactic protein-1 (MCP1)), two important 
proinflammatory cytokines (tumor necrosis factor alpha (TNFα) and interleukin-1β (Il1β)) and the gene coding 
for cyclooxygenase (COX-2) that produces prostaglandin E2, a regulator of inflammation, both in the liver and 
the visceral adipose tissues24. Several markers of macrophage infiltration and/or inflammation were induced in 
the visceral adipose tissue (p < 0.05 ANOVA for Mcp1) and in the liver (p < 0.05 ANOVA for Mcp1, Cd11c, Il1b, 
Tnfa, F480) of ApoE−/− mice due to HF feeding as compared to CT group (Fig. 3). Among them, MCP1 was 
downregulated after CG supplementation; this effect was more pronounced and significant in combination with 
the PPE. In addition, the expression of the proinflammatory cytokine TNFα, Ilβ and COX-2 were downregu-
lated in the liver from mice treated with the combined supplementation (Fig. 3b). However, several circulating 
cytokines and biomarkers of inflammatory related to cell adhesion molecules (IL-6, IL-10, IL-1β, MIP1α, MCP1, 
TNFα, sE-Selectin, sICAM-1, PAI-1, proMMP-9) were not significantly influenced by the treatments (data not 
shown).
Chitin-glucan supplementation with pomegranate peel extract improved endothelial (dys)
function. Endothelial dysfunction was attested by atherosclerotic plaques in aorta isolated from ApoE−/− 
mice fed a HF diet (data not shown). In line with a potential reduced endothelial function25, aorta showed 
increased abundance of caveolin-1 (*p < 0.05 HF group versus CT group, ANOVA), the negative allosteric regu-
lator of endothelial NO synthase (eNOS) (Fig. 4a). We performed western blotting to assess the activating serine 
1177 phosphorylated form of endothelial NOS (p-eNOSser1177) in conductance (thoracic) versus resistance (mes-
enteric) arteries (Fig. 4b,c). Interestingly, the combination CG + PPE increased the activating form of eNOS in 
mesenteric arteries (Fig. 4c).
Mesenteric arteries segments were mounted in wire myograph in order to evaluate endothelial func-
tion. Resting parameters revealed no difference (after normalization) between the four groups concerning the 
basal tone, the maximal contraction after a KCl challenge and the mean arterial diameter (supplemental File 
1). The endothelium-dependent relaxation was studied upon acetylcholine addition in the incubation medium 
on pre-constricted arteries in the presence of a KCl-enriched solution and in the presence of a cyclooxygenase 
inhibitor (indomethacin) or a NO synthase inhibitor (L-NAME). Mesenteric arteries isolated from HF treated 
ApoE−/− mice relaxed less in response to acetylcholine than vessels obtained from ApoE−/− mice fed a control 
diet, suggesting the presence of endothelial dysfunction in HF fed mice whatever the supplementation (Fig. 5a). 
In contrast to incubation in the presence of indomethacin, this effect disappeared in the presence of NO synthase 
inhibitor (Fig. 5b), suggesting that HF diet worsened the NO-dependent endothelial dysfunction of ApoE−/− in 
mesenteric arteries. However, dietary supplementations did not significantly modify endothelium-dependent 
relaxation of mesenteric arteries (Fig. 5a–c). Importantly, to confirm an impact of CG + PPE on NOS/NO path-
way, we measured the level of circulating heme-nitrosylated hemoglobin (Hb-NO) in the mice venous blood by 
EPR (Fig. 5d). HF mice presented a decreased level of Hb-NO compared to CT mice. In line with result obtained 
with phosphorylated form of eNOS protein, CG + PPE mice displayed a 40% increase in Hb-NO levels as com-
pared with HF mice.
Chitin-glucan supplementation with pomegranate peel extract affected the gut microbiota 
composition in Apoe−/− mice fed a high fat diet. The differences within the intestinal microbial 
population between the four groups were visualized by Non Metric Dimensional Scaling built upon a Bray-curtis 
distance matrix based on the species taxonomic level (Fig. 6a). A distinct clustering was observed for each of 
the four groups of mice and was confirmed by AMOVA analysis of the dissimilarity matrix, albeit not for the 
CT HF CG CG + PPE
Liver (g) 0.96 ± 0.08a 1.21 ± 0.07b 1.25 ± 0.06b 1.24 ± 0.03b
Visceral adipose tissue (%) 0.44 ± 0.05 0.65 ± 0.07 0.59 ± 0.07 0.55 ± 0.07
Subcutaneous adipose tissue (%) 0.80 ± 0.06a 1.45 ± 0.20b 1.19 ± 0.11ab 1.14 ± 0.14ab
Epididymal adipose tissue (%) 0.96 ± 0.08a 1.88 ± 0.27b 1.54 ± 0.17b 1.51 ± 0.17ab
Cecal tissue (mg) 56 ± 5a 41 ± 2b 51 ± 2ab 56 ± 2a
Cecal content (mg) 239 ± 27 171 ± 15 221 ± 11 213 ± 17
Triglycerides (mM) 0.71 ± 0.09 0.73 ± 0.17 0.59 ± 0.06 0.60 ± 0.07
Non esterified fatty acids (mM) 0.54 ± 0.02 0.56 ± 0.09 0.45 ± 0.06 0.48 ± 0.06
Total cholesterol (mM) 9.78 ± 1.55a 16.68 ± 2.24b 14.92 ± 0.76b 15.90 ± 0.73b
Table 1. Organ weights and plasma lipids. ApoE−/− mice were fed a low fat diet (CT), a high fat (HF) diet or 
a HF diet supplemented with 5% chitin-glucan (CG) or a combination of 5% CG and 0.5% pomegranate peel 
extracts (CG + PPE) for 8 weeks. Data with different superscript letters are significantly different at p < 0.05 
(ANOVA).
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Figure 2. Lipid accumulation in the liver tissue. Hepatic content of lipids (a), cholesterol (b) and triglycerides 
(c) of ApoE−/− mice fed a low fat diet (CT), a high fat (HF) diet or a HF diet supplemented with 5% chitin-
glucan (CG) or a combination of 5% CG and 0.5% pomegranate peel extracts (CG + PPE) for 8 weeks. Lipid 
fraction area (d) and mean size of lipid droplets (e) were automatically analysed by ImageJ from Oil red O 
staining of frozen section of the main lobe of liver, bar = 100 µm (f). Data with different superscript letters are 
significantly different at p < 0.05 (ANOVA).
Figure 3. Expression of inflammatory markers in the visceral adipose tissue (a) and the liver (b). ApoE−/− 
mice were fed a high fat (HF) diet or a HF diet supplemented with 5% chitin-glucan (CG) or a combination of 
5% CG and 0.5% pomegranate peel extracts (CG + PPE) for 8 weeks. Data are expressed as the mean ± SEM. 
The dotted line depicts the relative values observed in ApoE−/− mice fed a low fat diet (set at 1). *p < 0.05 
versus HF group (ANOVA).
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CG + PPE versus CG groups (Supplementary File 1). We did not observe any significant effect on cecal microbial 
α-diversity (Fig. 6b). Despite the presence of different clustering, the relative abundances between phyla or family 
or genus due to CG and PPE supplementation were not significantly affected at the q-value by the dietary treat-
ment (Supplementary Dataset 1). However, it is important to mention that the abundances of Akkermansia and 
Alistipes among other bacterial genera were significantly different between the dietary treatments at the p-value. 
In addition to the sequencing of the cecal microbiota, we analyzed some specific bacteria with a complementary 
quantitative approach by using qPCR method on an educated guess basis, meaning that we selected bacteria 
for which previous reports have shown a link between these bacteria and inflammation/metabolic disorders: 
(1) several studies demonstrated that specific Bifidobacterium or Lactobacillus strains alone or in combination, 
decreased the metabolic alterations (decrease of body weight and fat mass gain) together with a reduction of 
the inflammatory events, occurring in the liver and/or the adipose tissue in diet-induced obesity models26,27; 
(2) a recent paper demonstrated that Roseburia interacted with dietary plant polysaccharides to lower systemic 
Figure 4. Western blot analyses on aorta (a,b) and mesenteric arteries (c) with anti-caveolin-1 (a) or anti-
phosphorylated endothelial NOS (eNOS)ser1177 (b,c). ApoE−/− mice were fed a high fat (HF) diet or a HF diet 
supplemented with 5% chitin-glucan (CG) or a combination of 5% CG and 0.5% pomegranate peel extracts 
(CG + PPE) for 8 weeks. Data are expressed as the mean ± SEM. Values are expressed relative to ApoE−/− mice 
fed a low fat diet (set at 1). *p < 0.05 versus HF group (ANOVA).
Figure 5. Endothelium-dependent relaxation of preconstricted mesenteric arteries and level of Hb-NO in 
venous blood. Endothelium-dependent relaxation was evaluated by cumulative addition of acetylcholine (Ach) 
on pre-contracted arteries with a high KCl-solution, in the absence (a) or the presence of nitric oxide synthase 
inhibitor Nω-Nitro-L-arginine methyl ester (b) or a cyclooxygenase inhibitor (c). Level of Hb-NO in venous 
blood (d). ApoE−/− mice were fed a low fat diet (CT), a high fat (HF) diet or a HF diet supplemented with 
5% chitin-glucan (CG) or a combination of 5% CG and 0.5% pomegranate peel extracts (CG + PPE) for 8 
weeks. Data with different superscript letters are significantly different at p < 0.05 (one-way ANOVA); ns = non 
significant and *p < 0.05 (two-way ANOVA).
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inflammation and ameliorated atherosclerosis in germ-free apolipoprotein E-deficient mice colonized with syn-
thetic microbial communities28. Moreover, our previous work showed that CG had metabolic interest that could 
be related to the increase in Roseburia spp. in a mouse model of HF induced-obesity21; (3) Alistipes were positively 
associated with HF-induced obesity in several independent studies29–31; (4) finally, Akkermansia is a bacterium 
capable of reducing adipose tissue inflammation and dyslipidaemia in obese mice26,27,32,33. The Fig. 7 shows that 
the increase of Alistipes spp. and Lactobacillus spp in the cecal content due to HF feeding was counteracted by the 
CG + PPE supplementation (Fig. 7e,f). Akkermansia muciniphila were also significantly decreased by the com-
bination CG + PPE compared to the HF fed group (Fig. 7d). We did not observe any changes in total bacteria, 
Roseburia spp. and Bifidobacterium spp. (Fig. 7a–c).
Discussion
The nutritional quality of diets underlies or exacerbates several chronic pathologies, including CVD34,35. Western 
diets are high in calories, simple sugars, saturated fat and are also characterized by an imbalance in the dietary 
intake of n-3 and n-6 PUFA36. In a recent study, we demonstrated that n-3 PUFA depletion for 12 weeks could 
accelerate the process of endothelium dysfunction in young ApoE−/− mice prone to develop atherosclerosis19. 
Another study demonstrated that consumption of HF diet (60% kJ from fat) during 17 weeks promotes obesity 
and accelerates atherosclerosis in ApoE−/− mice7. This effect was accompanied by the development of a meta-
bolic syndrome phenotype characterized by a low level of inflammation and atherosclerotic lesion7. In the present 
study, we show that HF feeding (60% kcal from fat and 0.15% cholesterol) induces obesity, hypercholesterolemia, 
inflammatory disorders and endothelial dysfunction in young (10-wk-old at the beginning of the treatment) 
ApoE−/− mice fed a HF diet for only 8 weeks. We then used this model to test the health benefits of original 
nutrients in the management of endothelial and inflammatory dysfunctions associated with CVD.
The health-promoting effect of prebiotic fibre and plant extracts is subject to interesting developments37. 
Chitin-glucan (CG), a natural component of the cell wall of microscopic fungi has been approved as a novel 
food ingredient after a positive safety evaluation in 2010 by the European Food Safety Authority38. The CG used 
in the present study is a high-purity biopolymer extracted from the mycelium of Aspergillus niger. This insolu-
ble fiber is composed of two types of polysaccharide chains, namely chitin (poly-N-acetyl-D-glucosamine) and 
beta-(1,3)-D-glucan (D-glucose units linked predominantly via beta-(1,3) linkage). We previously demonstrated 
Figure 6. Microbiota structure assessed by non-metric dimensional scaling (NMDS) and bacterial diversity. 
A four dimensional model, built on a species level dissimilarity matrix has been obtained with a stress value of 
0.08 (a). Reciprocal Simpson alpha-diversity, Chao richness and Simpson evenness (b) assessed from amplicon 
sequencing data of microbial cecal content of ApoE−/−mice fed, a low fat diet (CT), a high fat (HF) diet or 
a HF diet supplemented with 5% chitin-glucan (CG) or a combination of 5% CG and 0.5% pomegranate peel 
extracts (CG + PPE) for 8 weeks (p > 0.05 ANOVA, Kruskal-Wallis test).
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its beneficial effects on the development of obesity and associated diabetes and hepatic steatosis in HF-fed mice, 
through a mechanism related to the restoration of the composition and/or the activity of gut bacteria [33]. On the 
other side, health benefits of pomegranate fruit and/or juice consumption have recently received considerable sci-
entific focus. The PPE used in this study is a source of polyphenol (40%), with punicalagin and ellagic acid levels 
reaching 10% and 2%, respectively. Our previous findings support that pomegranate extract constitutes a prom-
ising food ingredient to control atherogenic and inflammatory disorders associated with diet-induced obesity 
since it alleviated tissue inflammation and hypercholesterolaemia in HF diet-induced obese mice23. In line with 
our previous results, here we observe that CG + PPE reduces several proinflammatory parameters such as the 
expression of the chemokine MCP-1 (involved in the recruitment of inflammatory cells inside the tissue) in both 
the visceral and liver tissues and the expression of the proinflammatory cytokines IL-1β and TNFα in the liver.
The presence of hepatic steatosis has previously been reported for ApoE−/− mice fed a HF diet and the model 
has been proposed to study features of nonalcoholic fatty liver disease (NAFLD) on cardiovascular events38,39. 
In the present study, HF feeding did not induce higher lipid accumulation in the liver of ApoE−/− mice than 
the low fat diet. This is probably due to the short-term dietary treatment investigated here. Importantly, the sup-
plementation with CG + PPE reduced significantly hepatic triglycerides, one of the critical features of NAFLD. 
Further studies are needed to unravel the mechanism behind the lower hepatic fat accumulation since two key 
genes in the liver that regulate lipid metabolism (FAS and CPT-1) were not affected by the dietary treatments.
Metabolic diseases such as NAFLD are associated with macro- and microcirculation damage, initiating an 
impairment of endothelium-dependent relaxation39,40. Eight weeks of HF-diet were able to accelerate the process 
of endothelial dysfunction in aorta namely by increasing abundance of caveolin-1, a negative allosteric regulator 
of eNOS leading to endothelial dysfunction exacerbation and associated CVD25,41. However, the dietary combi-
nation did not affect this parameter in the aorta, the major representative conductance vessel of the macrocircu-
lation. We used western blotting to assess the activation of eNOS through analysis of its phosphorylated forms 
(p-eNOSser1177) both in conductance (thoracic) and resistance (mesenteric) arteries. We observed that the acti-
vated form of eNOS was a third higher in mesenteric arteries due to supplementation with CG + PPE compared 
to HF ApoE−/− mice, suggesting that the innovative dietary combination activated the NOS/NO pathway in the 
resistance arteries representing the microcirculation near the gut. Furthermore, we investigated the relaxation 
profile of mesenteric arteries. We demonstrated that HF feeding for 8 weeks accelerated the process of endothelial 
dysfunction in resistance mesenteric arteries in ApoE−/− genotype, as already shown in previous studies42,43. We 
concluded that prostanoids do not play an major role in this early stage of endothelial dysfunction, based on the 
lack of effect of indomethacin, a non-selective cyclooxygenase inhibitor. In most cases, endothelial dysfunction is 
related to a reduced NO availability in mice6. Accordingly, impairment of endothelial function due to HF feeding 
is mainly dependent on a reduced NO bioavailability in ApoE−/− mice as L-NAME (a NOS inhibitor), coun-
teracted the vasorelaxation of mesenteric arteries from all mice and repealed the differences between genotypes, 
independently of the dietary conditions. In contrast, resting parameters (vessel diameter and basal tone) and 
contraction profile (response to KCl challenge stimulation) of mesenteric arteries were not affected by the HF 
treatment whatever the dietary supplementations. In our experimental setting, CG + PPE supplementation did 
Figure 7. Cecal bacteria assessed by qPCR. Total bacteria (a), Bifidobacterium spp. (b), Akkermansia 
muciniphila (c), Roseburia spp. (d), Alistipes spp. (e), Lactobacillus spp. (f) in the cecal content of ApoE−/−
mice fed, a low fat diet (CT), a high fat (HF) diet or a HF diet supplemented with 5% chitin-glucan (CG) or a 
combination of 5% CG and 0.5% pomegranate peel extracts (CG + PPE) for 8 weeks. Data are Whiskers plots 
with minimum and maximum. Data with different superscript letters are significantly different at p < 0.05 
(ANOVA, Kruskal-Wallis test).
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not improve the NO-dependent endothelium relaxation measured in mesenteric arteries. Of more relevance for 
human CVD, the effects of CG + PPE supplementation were not restricted to the phosphorylated form of eNOS 
in enteric vascular tree since this dietary treatment also increased the circulating levels of Hb-NO in peripheral 
blood at distance from the mesenteric bed. Altogether, our results demonstrate that, besides interesting hepatic 
events highlighted above, the supplementation with CG and PPE for 8 wk improved the endothelial function with 
consequences on systemic NO bioavailability in HF-fed ApoE−/− mice. It was previously shown that pomegran-
ate extract administrated alone during 30 days enhanced endothelium-dependent artery relaxation although it 
concerned coronary arteries isolated from perfused hearts of spontaneously hypertensive ovariectomized rats44. 
Furthermore, they demonstrated in the same study that the treatment with their extract inhibited p-eNOS Thr495 
without affecting p-eNOS Ser1177, improved lipid profile and was able to prevent the reduction in plasma nitrite 
levels spontaneously induced by castration.
Gut microbiota plays a crucial role in the control of host intestinal functions and management of NAFLD, 
through the release and/or biotransformation of metabolites (eg, bile acids and short chain fatty acids) which 
regulate gut endocrine function12. Establishing the causal and consequential actions of the gut microbiota in 
driving obesity and related-metabolic diseases has been challenging. Interestingly, Stepankova et al.45 reported 
that germ-free ApoE−/− mice developed more aortic atherosclerotic plaques compared with conventionally 
raised ApoE−/− mice fed the same low standard cholesterol diet. Along the same lines, compared to germ-free 
mice, the levels of cholesterol and triglycerides in plasma of conventionally raised mice are reduced, whereas 
they are increased in adipose tissue and liver46. Both findings support the hypothesis of a protective ability for the 
gut microbiota in CVD and in the management of plasma levels of cholesterol and lipids10. We have previously 
shown that the improvement of vascular dysfunction by ITF was linked to an activation of the NOS/NO path-
way, which could be dependent on events occurring at the gut microbiota level (namely, through an increase in 
NO-producing bacteria). Although dietary treatment induced clusterization due to CG and CG + PPE supple-
mentation, our targeted microbiota characterization did not reveal any changes in bacterial diversity or relative 
abundance of bacteria whatever the taxonomical level considered. However, the CG and PPE counteracted the 
effect of the HF feeding on the abundance of Alistipes spp and Lactobacillus spp present in the cecal content of 
mice only when these compounds were combined. Recently, Moschen and colleagues identified Alistipes spp. as 
one of the top ten most abundant genera associated with human colorectal carcinoma and provide experimental 
evidence that Alistipes potently induces inflammation in colitis-prone Il10−/− mice47. In line with this finding, 
Alistipes were positively associated with HF-induced obesity in several independent studies29–31. The depletion of 
Alistipes by CG + PPE in the current study is particularly relevant, considering that in both studies, they demon-
strated that transmissible microbial and metabolomic remodeling by dietary fiber improved metabolic homeosta-
sis29,30. Our results indicated that Lactobacillus spp. and Akkermansia muciniphila are other bacteria susceptible 
to dietary manipulation. It has been reported that members of the Lactobacillus, Akkermansia muciniphila and 
Bifidobacterium genera may play a critical role as anti-obesity drivers in experimental models and humans32,48,49. 
One study linked specific species of Lactobacillus (L. reuteri) with obesity in humans50 whereas many studies 
tested for their ability to affect positively obesity and risk factors associated with CVD26,51. Here, the Lactobacillus 
genus increased upon HF feeding whereas the supplementation with CG + PPE blunted this effect. The study of 
Fak and Backhed demonstrated that bacterial strains of the same Lactobacillus species showed different effects on 
adiposity and insulin sensitivity in ApoE−/− mice, illustrating the complexity of host bacterial cross-talk and the 
importance of strain specificity52. In this context, it would be of interest to further characterize the identity and 
the functionality of the Lactobacillus strains affected by the dietary treatments. Although Akkermansia muciniph-
ila is a bacterium capable of reducing fat mass development, insulin resistance, metabolic endotoxemia, adipose 
tissue inflammation and dyslipidaemia in obese mice and in a pilot study conducted in humans32,33, we observed 
a decreased abundance of this bacteria in the cecal content of ApoE−/− mice treated with the combination 
CG + PPE. Our previous work showed that CG had metabolic interest that could be dependent on the increase in 
Roseburia spp. in a mouse model of HF induced-obesity21 but their level was not impacted the dietary treatments 
in the model of HF-fed ApoE−/− mice. Therefore, we proposed that neither Akkermansia nor Roseburia spp. 
were involved in the metabolic and anti-inflammatory effects of the combined treatment (CG + PPE) observed 
in the present study. These data also clearly support the notion that we should not generalize the effects of dietary 
fibers and polyphenols on Akkermansia, as discussed in a recent review, predicting which fibers or polyphenols 
are the most suited to maximize beneficial health effects is highly dependent on the health situation, the individ-
ual and its microbiota53
In conclusion, our study demonstrated that food supplementation with CG and PPE limited triglyceride accu-
mulation in the liver and exerted anti-inflammatory effects both in the liver and in the visceral adipose tissue of 
ApoE−/− mice fed a HF diet. In addition, the combination improved endothelial function in mesenteric arteries 
through a higher production and availability of NO in this model. Gut bacteria such as Lactobacillus and Alistipes 
could be implicated in the management of metabolic and inflammatory dysfunctions associated with CVD. The 
beneficial effects were observed only when CG was associated with PPE in the diet, confirming a previous study 
that highlighted the need to consider the interactions among bioactive food components when evaluating poten-
tial prebiotic effects of dietary fiber54.
Methods
ethics statement. All experiments were performed in strict accordance with relevant guidelines and reg-
ulations for the care and use of animals and in accordance with the EU directive. All mouse experiments were 
approved by and performed in accordance with the guidelines of the local ethics committee for animal care of the 
Health Sector of the Université catholique de Louvain under the specific agreement numbers 2017/UCL/MD/005. 
Housing conditions were as specified by the Belgian Law of 29 May 2013, on the protection of laboratory animals 
9Scientific RepoRtS |         (2019) 9:14150  | https://doi.org/10.1038/s41598-019-50700-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
(Agreement LA 1230314). Every effort was made to minimize animal pain, suffering, and distress and to reduce 
the number of animals used.
Animals and experimental design. Nine weeks old male and ApoE−/− mice (B6.129P2-Apoetm1Unc/J 
from Charles River Laboratories, L’Arbresle, France) were housed two or three mice per cage (environmental 
enrichment: plastic tunnels and sheets) and with a 12 h light/dark cycle at 22 °C, diet and water were ad libi-
tum. Mice were fed a low fat (10 kJ%), no sucrose, purified ingredient diet (CT, E157452-047, Ssniff, Germany) 
or a high fat (HF) diet (60 kJ% fat, 0.15% cholesterol, S8899-E730, Ssniff, Germany) for 8 weeks. HF-fed mice 
were supplemented with or without 5% CG (Kitozyme, Belgium) and a combination of 5% CG and 0.5% PPE 
(Oxylent, Belgium). CG used in the study was derived from the cell walls of the mycelium of Aspergillus niger, in 
which two types of polysaccharide chains, i.e., chitin (poly N-acetyl-D-glucosamine) and β(1,3)-D-glucan, are 
associated. PPE extract (OXYLENT®GR, Oxylent S.A.) used in the study was derived from pomegranate peel in 
which polyphenol content reached 40% (Folin–Ciocalteu method, equivalent gallic acid) and the concentrations 
of punicalagin and ellagic acid were 10 and 2% (ultra-performance liquid chromatography method with diode 
array detection), respectively.
The data provided in the manuscript are issued from 2 separate experiments, performed in the same animal 
facility, one for measurement of vascular contraction and relaxation and western blot analysis of mesenteric arter-
ies (experiment A, n = 8 per group) and one for other parameters (experiment B, n = 9 per group). Body compo-
sition was assessed every two weeks by using 7.5 MHz time domain-NMR (LF50 minispec, Bruker, Rheinstetten, 
Germany).
Experiment A. After a total of 8 weeks of dietary treatment, mice were anaesthetized in postprandial state 
(Anesketin®, Ketamin hydrochloride and Rompun®, xylazine hydrochloride i.p., 100 and 10 mg/kg of body 
weight, respectively). Second and third order mesenteric arteries were rapidly removed and carefully isolated 
from visceral adipose and/or connective tissues as previously described55.
Experiment B. After a total of 8 weeks of dietary treatment and a 6-h period of fasting, mice were anesthetized 
with isoflurane (Forene®, Abbott, Queenborough, Kent, England) and blood samples were harvested. We col-
lected venous blood (0.2 mL) from the right ventricle, immediately frozen in heparinized calibrated tube in liquid 
nitrogen. Venous blood samples were also collected and centrifuged (3 min at 13,000 g) for further analysis. Liver, 
aorta, adipose tissues and caecum were carefully dissected, weighted and immersed in liquid nitrogen before 
storage at −80 °C; pieces of liver and aorta were embedded in OCT compound and frozen in nitrogen cooled 
isopentane for histology.
Measurement of nitric oxide bioavailability by electron paramagnetic resonance. The level of 
circulating heme-nitrosylated haemoglobin (Hb-NO) was assayed in whole blood of mice from the electron par-
amagnetic resonance (EPR) signal of 5-coordinate-α-Hb-NO as previously described55.
Blood biochemical analyses. Plasma triglycerides, total cholesterol and non-esterified fatty acid lev-
els were analyzed in venous blood using kits (Diasys Diagnostic and Systems, Holzheim, Germany; Randox 
Laboratories, Crumlin, United Kingdom). Alanine aminotransferase (ALAT) levels were measured in the serum 
as a marker of liver damage using the ALAT/GPT kit (DiaSys Diagnostic and Systems). Plasma concentrations 
of cardiovascular analytes (sE-Selectin, sICAM-1, PAI-1 Total, proMMP-9) and of cytokines (IL-6, IL-10, IL-1β, 
MIP1α, MCP1 and TNFα) were determined using two multiplex immunoassay kits (Milliplex kits from Merck 
Millipore based on Luminex® technology (Bioplex®, Bio-Rad, Belgium)). Triglycerides and cholesterol were 
measured in the liver tissue after extraction with chloroform–methanol according to the Folch method, as previ-
ously described56.
Histological analysis. Sections of aortic arch, previously isolated from connective tissues, were fro-
zen in embedding medium (Tissue-tek, Sakura, The Netherlands). Sections of artic arch of 5 µm were cut at 3 
different levels for each sample. Haematoxylin-eosin stained sections were digitalized at a 20x magnification 
using a SCN400 slide scanner (Leica, Wetzlar, Germany). Frozen sections of the main liver lobe (embedding in 
Tissue-tek) were sliced and stained with the Oil Red O. Haematoxylin-eosin stained sections were digitalized at a 
20x magnification using a SCN400 slide scanner (Leica, Wetzlar, Germany). The quantification of positive area/
tissue area was determined by thresholding for the Oil Red O signal (software TissueIA, version 4.0.7).
Real-Time quantitative PCR. Total RNA from tissues was extracted with TriPure reagent (Roche, 
Basel, Switzerland). cDNA was obtained by reverse transcription of 1 μg total RNA (Reverse Transcription 
System kit, Promega, Leiden, The Nederlands). Real-time qPCRs were performed using Mesa Fast qPCRTM 
(Applied Biosystems, Den Ijssel, The Netherlands and Eurogentec, Seraing, Belgium) for detection as previously 
described56. Ribosomal 7 protein L19 (RPL19) RNA was the housekeeping gene. Sequences of the primers are 
given in Supplementary File 1. All samples were run in duplicate and data were analyzed according to the 2−ΔΔCT 
method.
Western blot. Equal amount proteins from thoracic aorta and mesenteric arteries were separated by SDS/
PAGE and transferred to nitrocellulose membrane, blocked with 5% non-fat dry milk or bovine serum albu-
min (BSA) in tris-buffered saline tween-20. The membranes were incubated overnight at 4 °C with antibodies 
as previously described19. Gels were analysed and quantified by ImageQuantTM TL instrument (GE Healthcare, 
Buckinghamshire, England).
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Gut microbiota analyses. Genomic DNA was extracted from the cecal content using a QIAamp DNA 
Stool Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions, including a bead-beating 
step. 16S rDNA profiling, targeting V1-V3 hypervariable region and sequenced on Illumina MiSeq were per-
formed as described previously57 and detailed in Supplementary File 1. For total bacteria, Bifidobacterium spp., 
Roseburia spp., Akkermansia muciniphila and Lactobacillus spp. quantification by qPCR, primers are detailed in 
Supplementary File 1 and conditions were based on 16S rRNA gene sequence and was described earlier21,33. For 
Alistipes spp., method was detailed in Supplementary File 1.
Statistical analysis. Data are presented as mean ± SEM. Within-groups variances were compared 
using a Bartlett’s test. If variances were significantly different between groups, values were normalized by 
Log-transformation before proceeding to the analysis. Dixon’s Q-test was performed to statistically reject outliers 
(95% confidence level). Differences between groups were assessed using one-way ANOVA, followed by the Tukey 
post hoc test. For cecal bacteria, we used the non-parametric Kruskal-Wallis test. Data with different superscript 
letters were significantly different (p ≤ 0.05) according to the post hoc ANOVA statistical analysis. Grouped anal-
yses were assessed by two-way ANOVA. Statistical analyses were performed using GraphPad Prism version 7.04 
for windows.
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